Basic Information
| LncRNA/CircRNA Name | ERICH1-AS1 |
| Synonyms | DLGAP2, C8orf68, DAP2, ERICH1-AS1, SAPAP2 |
| Region | GRCh38_8:737596-1708474 |
| Ensemble | ENSG00000198010 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | Microarray, qPCR etc. |
| Sample | NSCLC tissues |
| Expression Pattern | up-regulated |
| Function Description | We discovered that three lncRNAs (RP11-397D12.4, AC007403.1, and ERICH1-AS1) were up regulated in NSCLC, compared with cancer-free controls. RP11-397D12.4, AC007403.1, and ERICH1-AS1 may be potential biomarkers for predicting the tumorigenesis of NSCLC in the future. |
| Pubmed ID | 26393913 |
| Year | 2015 |
| Title | Three circulating long non-coding RNAs act as biomarkers for predicting NSCLC. |
External Links
| Links for ERICH1-AS1 | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |